Review of India's Covaxin shot underway, WHO says

[October 26, 2021]    GENEVA (Reuters) - A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi

"If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing.

Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval.

(Reporting by Emma Farge; Editing by Andrew Cawthorne)

[© 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.